Marijuana and Cannabinoids in Epilepsy

Note: This course is included in the Marij-thon®: Comprehensive Medical Marijuana Course.

Health Effects of Marijuana and Cannabinoids in Epilepsy describes how the endocannabinoid system may affect seizure threshold, and reviews the available research and clinical evidence for the use of marijuana or cannabinoids in the treatment of epilepsy. In addition, there is a discussion about an FDA-approved cannabis-based medicine for the treatment of Dravet syndrome and Lennox-Gastaut syndrome which are two rare and severe forms of epilepsy.

$50.00

Bulk pricing is available! Click here to learn more.

Overview

Marijuana and Cannabinoids in Epilepsy describes how the endocannabinoid system may affect seizure threshold, and reviews the available research and clinical evidence for the use of marijuana or cannabinoids in the treatment of epilepsy.  In addition, there is a discussion about an FDA-approved cannabis-based medicine for the treatment of Dravet syndrome and Lennox-Gastaut syndrome which are two rare and severe forms of epilepsy.

Subscribers can complete the curriculum and refer back to the content at any point during their 12-month subscription period.

Content provides Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE), American Association of Nurse Practitioners (AANP), American Nurses Credentialing Center (ANCC), American Psychological Association (APA) credits, and American General Dentistry (AGD) PACE credits.

I don’t plan on recommending marijuana…why would I take this course?

Whether or not you have any intention of recommending medical marijuana for patient care, you need to be well educated in this clinical area because your patients will be seeking your expert advice and guidance for this medication. Further, some of your patients may already be utilizing medical marijuana and you will need to be aware of its physiologic effects as well as its  potential drug interactions. As such, expertise in the endocannabinoid system and medical marijuana is paramount for most doctors, pharmacists, nurses, psychologists, and other allied health professionals to remain that respected guide for their patients’ overall healthcare.

Editorial Team

Editor-in-Chief:
Meredith Fisher-Corn, MD

Founding Editor-in-Chief:
Stephen B. Corn, MD

Additional Details

Mobile-friendly: Yes